Results from 2 randomized, double-blind, placebo-controlled studies of the novel nk1 receptor antagonist casopitant in patients with major depressive disorder

10.1097/JCP.0b013e31823608ca

Saved in:
Bibliographic Details
Main Authors: Ratti, E., Bellew, K., Bettica, P., Bryson, H., Zamuner, S., Archer, G., Squassante, L., Bye, A., Trist, D., Krishnan, K.R., Fernandes, S.
Other Authors: DUKE-NUS GRADUATE MEDICAL SCHOOL S'PORE
Format: Article
Published: 2014
Subjects:
Online Access:http://scholarbank.nus.edu.sg/handle/10635/110626
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: National University of Singapore
id sg-nus-scholar.10635-110626
record_format dspace
spelling sg-nus-scholar.10635-1106262023-10-26T08:53:19Z Results from 2 randomized, double-blind, placebo-controlled studies of the novel nk1 receptor antagonist casopitant in patients with major depressive disorder Ratti, E. Bellew, K. Bettica, P. Bryson, H. Zamuner, S. Archer, G. Squassante, L. Bye, A. Trist, D. Krishnan, K.R. Fernandes, S. DUKE-NUS GRADUATE MEDICAL SCHOOL S'PORE casopitant depression GW679769 NK 1 antagonist receptor occupancy sleep 10.1097/JCP.0b013e31823608ca Journal of Clinical Psychopharmacology 31 6 727-733 JCPYD 2014-11-26T09:05:12Z 2014-11-26T09:05:12Z 2011-12 Article Ratti, E., Bellew, K., Bettica, P., Bryson, H., Zamuner, S., Archer, G., Squassante, L., Bye, A., Trist, D., Krishnan, K.R., Fernandes, S. (2011-12). Results from 2 randomized, double-blind, placebo-controlled studies of the novel nk1 receptor antagonist casopitant in patients with major depressive disorder. Journal of Clinical Psychopharmacology 31 (6) : 727-733. ScholarBank@NUS Repository. https://doi.org/10.1097/JCP.0b013e31823608ca 02710749 http://scholarbank.nus.edu.sg/handle/10635/110626 000296742000009 Scopus
institution National University of Singapore
building NUS Library
continent Asia
country Singapore
Singapore
content_provider NUS Library
collection ScholarBank@NUS
topic casopitant
depression
GW679769
NK 1 antagonist
receptor occupancy
sleep
spellingShingle casopitant
depression
GW679769
NK 1 antagonist
receptor occupancy
sleep
Ratti, E.
Bellew, K.
Bettica, P.
Bryson, H.
Zamuner, S.
Archer, G.
Squassante, L.
Bye, A.
Trist, D.
Krishnan, K.R.
Fernandes, S.
Results from 2 randomized, double-blind, placebo-controlled studies of the novel nk1 receptor antagonist casopitant in patients with major depressive disorder
description 10.1097/JCP.0b013e31823608ca
author2 DUKE-NUS GRADUATE MEDICAL SCHOOL S'PORE
author_facet DUKE-NUS GRADUATE MEDICAL SCHOOL S'PORE
Ratti, E.
Bellew, K.
Bettica, P.
Bryson, H.
Zamuner, S.
Archer, G.
Squassante, L.
Bye, A.
Trist, D.
Krishnan, K.R.
Fernandes, S.
format Article
author Ratti, E.
Bellew, K.
Bettica, P.
Bryson, H.
Zamuner, S.
Archer, G.
Squassante, L.
Bye, A.
Trist, D.
Krishnan, K.R.
Fernandes, S.
author_sort Ratti, E.
title Results from 2 randomized, double-blind, placebo-controlled studies of the novel nk1 receptor antagonist casopitant in patients with major depressive disorder
title_short Results from 2 randomized, double-blind, placebo-controlled studies of the novel nk1 receptor antagonist casopitant in patients with major depressive disorder
title_full Results from 2 randomized, double-blind, placebo-controlled studies of the novel nk1 receptor antagonist casopitant in patients with major depressive disorder
title_fullStr Results from 2 randomized, double-blind, placebo-controlled studies of the novel nk1 receptor antagonist casopitant in patients with major depressive disorder
title_full_unstemmed Results from 2 randomized, double-blind, placebo-controlled studies of the novel nk1 receptor antagonist casopitant in patients with major depressive disorder
title_sort results from 2 randomized, double-blind, placebo-controlled studies of the novel nk1 receptor antagonist casopitant in patients with major depressive disorder
publishDate 2014
url http://scholarbank.nus.edu.sg/handle/10635/110626
_version_ 1781788893335519232